Greetings. Welcome to TG Therapeutics Second Quarter 2021 Earnings Call and Business Update. [Operator Instructions]
At this time, I will now turn the conference over to Jenna Bosco, Senior Vice President of Corporate Communications. Jenna, you may now begin.
Jenna Bosco
Senior Vice President, Corporate Communications
Thank you. Welcome everyone and thanks for joining us this morning. I m Jenna Bosco and with me today to discuss the second quarter 2021 financial results and provide a business update are Michael Weiss, our Chairman and Chief Executive Officer; Adam Waldman, our Chief Commercialization Officer; and Sean Power, our Chief Financial Officer. Following our Safe Harbor statement, Mike will provide an overview of our recent corporate developments as well as an update on our current pivotal programs and remaining key goals for 2021. Adam will then provide an update on our commercialization efforts and Sean will provide a brief overview of our financial results, before
Operator
Greetings and welcome to TG Therapeutics Q1 2021 Earnings Conference Call and Business Update. [Operator Instructions] I would now like to turn the conference over to Jenna Bosco, Senior VP of Corporate Communications. Please proceed.
Jenna Bosco
Senior Vice President, Corporate Communications
Thank you. Welcome, everyone, and thanks for joining us this morning. I m Jenna Bosco, and with me today to discuss the first quarter 2021 financial results and provide a business update are Michael Weiss, our Executive Chairman and Chief Executive Officer; Adam Waldman, our Chief Commercialization Officer; and Sean Power, our Chief Financial Officer. Following our Safe Harbor statement, Mike will provide an overview of our recent corporate developments as well as an update on our current pivotal programs and key goals for 2021, Adam will provide an update on our commercialization efforts, and Sean will provide a brief overview of our financial results before turning the call o